Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting

RARECARENet Working Group

    Research output: Contribution to journalArticlepeer-review

    12 Citations (Scopus)

    Abstract

    The management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of databases, translational research programs, and clinical trials. Access to innovative strategies represents a major challenge, as there is a lack of funding for clinical research in rare cancers and their rarity precludes the design of robust clinical trials that could lead to specific approval of drugs. In this context, patient-centered initiatives, such as the establishment of dedicated networks, are warranted. International societies, such as IMIG (International Mesothelioma Interest Group) and ITMIG (International Thymic Malignancy Interest Group) provide infrastructure for global collaboration, and there are many advantages to having strong regional groups working on the same issues. There may be regional differences in risk factors, susceptibility, management and outcomes. The ability to address questions both regionally as well as globally is ideal to develop a full understanding of mesothelioma and thymic malignancies. In Europe, through the integration of national networks with EURACAN, the collaboration with academic societies and international groups, the development of networks in thoracic oncology provides multiplex integration of clinical care and research, ultimately ensuring equal access to high quality care to all patients, with the opportunity of conducting high level clinical and translational research projects.

    Original languageEnglish
    Pages (from-to)75-80
    Number of pages6
    JournalEuropean Journal of Surgical Oncology
    Volume45
    Issue number1
    DOIs
    Publication statusPublished - Jan 2019

    Bibliographical note

    Funding Information:
    This research was partly funded by the European Commission through the Consumers, Health, Agriculture and Food Executive Agency ; Grant No. 2000111201 ; Information network on rare cancers-RARECARENet.

    Publisher Copyright:
    © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology

    Fingerprint

    Dive into the research topics of 'Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting'. Together they form a unique fingerprint.

    Cite this